BioCentury
ARTICLE | Clinical News

Eculizumab: Started Phase III

November 8, 2004 8:00 AM UTC

ALXN will begin the open-label, international Phase III SHEPHERD trial in 75 patients. The trial has an SPA from FDA. ...